Loss of ER altered expression of co-regulatory proteins (CRPs), as well as increases in the number of ER-negative CSCs in the ER+ tumor, and lncRNAs mediates and contributes to tamoxifen resistance in BC [157–159]. The gene discussed is ESR1; the disease is breast cancer.